SavedAdd your journal

Journals / Turkish Journal of Biology / 2016 / Cilt: 40 - Sayı: 4

Potential therapeutic effects of silymarin and silymarin-loaded solid lipidnanoparticles on experimental kidney damage in BALB/c mice: biochemical and histopathological evaluation

Mustafa CENGİZ
Hatice Mehtap KUTLU
Ahmet MUSMUL
Adnan AYHANCI
Pages
807–814
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our biochemical and light microscopic results suggest that the group that received Sm-SLNs for the treatment of D-GalN/TNF-α-induced experimental kidney damage showed significantly more improvement than the group that received commercially available Sm.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Silymarin (Sm) is widely used in treating diseases that affect organs such as the liver, kidney, and gallbladder thanks to its antioxidative, renoprotective, antihepatotoxic, and anticarcinogenic properties.
📊
Key Findings & Data:Our biochemical and light microscopic results suggest that the group that received Sm-SLNs for the treatment of D-GalN/TNF-α-induced experimental kidney damage showed significantly more improvement than the group that received commercially available Sm.
💡
Conclusion & Impact:In conclusion, Sm-loaded SLN may be a useful system for the delivery of poorly water-soluble Sm and may also provide renoprotection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Silymarin (Sm) is widely used in treating diseases that affect organs such as the liver, kidney, and gallbladder thanks to its antioxidative, renoprotective, antihepatotoxic, and anticarcinogenic properties. However, this substance is poorly solved in water and tends to decompose in the intestine, its bioavailability decreasing before it can show real effect. With these limitations in mind, the present study aims to enhance the poor bioavailability of Sm by forming Sm-loaded solid lipid nanoparticles (Sm-SLNs) using the hot homogenization method. A characterization process was undertaken to determine possible impact of Sm on experimental kidney damage. Our biochemical and light microscopic results suggest that the group that received Sm-SLNs for the treatment of D-GalN/TNF-α-induced experimental kidney damage showed significantly more improvement than the group that received commercially available Sm. In conclusion, Sm-loaded SLN may be a useful system for the delivery of poorly water-soluble Sm and may also provide renoprotection.

🔖

Cite This Article

CENGİZ, M., KUTLU, H. M., MUSMUL, A., AYHANCI, A. (2022). Potential therapeutic effects of silymarin and silymarin-loaded solid lipidnanoparticles on experimental kidney damage in BALB/c mice: biochemical and histopathological evaluation. Turkish Journal of Biology, Cilt: 40 - Sayı: 4, 807–814. https://ajindex.com/articles/600351

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Al-Haj N, Rasedee A (2009). Solid lipid nanoparticles preparation and characterization. Int J Pharmacol 1: 90-93.
  2. Anand R, Harry D, Holt S, Milner P, Dashwood M, Goodier D, Jarmulowicz M, Moore K (2002). Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut 50: 111-117.
  3. Basaga H, Poli G, Tekkaya C, Aras I (1997). Free radical scavenging and anti-oxidative properties of ‘silibin’ complexes on microsomal lipid peroxidation. Cell Biochem Funct 15: 27-33.
  4. Bertoli D, Segal S (1966). Developmental aspects and some characteristics of mammalian galactose 1 phosphate uridyltransferase. J Biol Chem 241: 4023-4029.
  5. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, Pohl LR (2002). Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298.
  6. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C (1998). Mechanism of hepatic toxicity. TNF-induced liver injury. Am J Physiol 275: 387-392.
  7. Cuatrecasas P, Segal S (1965). Mammalian galactokinase: developmental and adaptive characteristics in the rat liver. J Biol Chem 240: 2382-2388.
  8. Demirel M, Yazan Y, Muller RH, Kılıç F, Bozan B (2001). Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro and nanoparticles. J Microencapsul 18: 359-371.
  9. El-Shitany NA, El-Haggar S, El-Desoky K (2008). Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol 46: 2422-2428.
  10. Gezginci-Oktayoglu S, Tunali S, Yanardag R, Bolkent S (2008). Effects of Z-FA.FMK on D-galactosamine/tumor necrosis factor-alpha-induced kidney injury and oxidative stress in mice. Mol Cell Biochem 309: 9-20.
  11. Karimi G, Ramezani M, Tahoonian Z (2005). Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Adv Access Publication 26 July 2005 eCAM 2: 383-386.
  12. Koppel DE (1972). Analysis of macromolecular dispersity in intensity correlation spectroscopy: the method of cumulants. J Chem Phys 57: 4814. Kren V, Walterová D (2005). Silybin and Sm—new effects and applications. Biomed Pap 149: 29-41
  13. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A (1994). Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 153: 1778-1788.
  14. Lorenz D, Lucker P, Mennicke W, Wetzelsberger N (1984). Pharmacokinetic studies with silymarin in human serum and bile. Method Find Exp C